Genscript Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	293.21	131.99	1,446	1,024	1,181	629.06
Short-Term Investments	103.99	264.37	376.22	228.89	222.53	137.46
Trading Asset Securities	541.16	224.87	105.3	210.82	2.21	5.87
Cash & Short-Term Investments	938.36	621.24	1,928	1,464	1,406	772.38
Cash Growth	-50.06%	-67.78%	31.71%	4.13%	82.00%	81.09%
Accounts Receivable	132.18	116.29	218.83	104.28	142.44	141.75
Other Receivables	-	19.84	80.66	66.13	22.46	20.32
Receivables	132.18	136.13	299.53	170.44	166.58	164.49
Inventory	38.8	31.1	53.35	59.94	44.36	31.75
Prepaid Expenses	-	2.93	1.99	2.13	5.48	3.68
Restricted Cash	22.71	17.92	33.07	27.2	1.44	7.47
Other Current Assets	44.76	25.67	37.25	41.53	15.49	13.41
Total Current Assets	1,177	834.98	2,353	1,765	1,639	993.17
Property, Plant & Equipment	597.88	595.62	728.73	624.67	486.91	379.23
Long-Term Investments	3,609	3,790	85.41	16.03	18.47	13.99
Goodwill	1.34	1.34	1.36	2.55	14.15	14.12
Other Intangible Assets	12.77	13.04	18.65	23.81	26.42	26.02
Long-Term Accounts Receivable	-	-	0.29	0.4	-	-
Long-Term Deferred Tax Assets	18.74	27.74	16.51	15.05	5.09	3.7
Other Long-Term Assets	18.15	15.81	183.26	98.93	43.77	17.17
Total Assets	5,435	5,278	3,387	2,546	2,234	1,447
Accounts Payable	51.73	29.84	39.96	55.76	30.18	23.38
Accrued Expenses	65.65	69.86	164.77	210.03	156.11	114.4
Short-Term Debt	137.42	88.75	56.94	33.23	-	44.06
Current Portion of Long-Term Debt	18.05	-	0.07	0.45	0.52	0.58
Current Portion of Leases	8.36	7.52	8.87	11.1	7.51	2.59
Current Income Taxes Payable	7.79	9.39	18.13	16.15	15.72	3.53
Current Unearned Revenue	42.54	47.36	98.58	44.33	35.47	84.79
Other Current Liabilities	269.01	54.63	107.49	174.93	167.79	54.58
Total Current Liabilities	600.53	307.34	494.81	545.98	413.31	327.91
Long-Term Debt	329.89	570.48	712.72	567.23	381.86	1.26
Long-Term Leases	54.81	56.99	63.91	44.01	27.35	6.51
Long-Term Unearned Revenue	13.09	13.03	64.68	2.01	15.54	288.55
Long-Term Deferred Tax Liabilities	13.71	5.84	5.62	8.01	7.73	7.03
Other Long-Term Liabilities	1.27	1.24	1.21	16.48	0.4	0.55
Total Liabilities	1,013	954.91	1,343	1,184	846.18	631.82
Common Stock	2.18	2.14	2.12	2.11	2.1	1.95
Additional Paid-In Capital	1,984	1,982	1,939	1,473	1,274	1,067
Retained Earnings	2,339	2,364	-597.73	-502.25	-275.4	-175.01
Treasury Stock	-4.24	-6.09	-9.45	-11.92	-15.75	-16.71
Comprehensive Income & Other	95.59	-20.56	56.87	49.57	60.78	24.92
Total Common Equity	4,416	4,321	1,391	1,011	1,046	901.71
Minority Interest	5.36	2.19	653.28	352.13	341.7	-86.11
Shareholders' Equity	4,421	4,323	2,044	1,363	1,388	815.59
Total Liabilities & Equity	5,435	5,278	3,387	2,546	2,234	1,447
Total Debt	548.52	723.74	842.5	656.02	417.24	55
Net Cash (Debt)	389.84	-102.5	1,085	807.69	988.47	717.38
Net Cash Growth	-56.19%	-	34.38%	-18.29%	37.79%	78.28%
Net Cash Per Share	0.18	-0.05	0.51	0.39	0.49	0.38
Filing Date Shares Outstanding	2,178	2,160	2,124	2,111	2,096	1,953
Total Common Shares Outstanding	2,178	2,144	2,123	2,111	2,096	1,953
Working Capital	576.28	527.64	1,858	1,219	1,226	665.26
Book Value Per Share	2.03	2.02	0.66	0.48	0.50	0.46
Tangible Book Value	4,402	4,307	1,371	984.18	1,005	861.57
Tangible Book Value Per Share	2.02	2.01	0.65	0.47	0.48	0.44
Land	-	320.67	350.49	265.52	188.58	175.82
Machinery	-	311.68	319.62	257.2	224.78	184.07
Construction In Progress	-	129.37	131.6	142.06	91.22	66.44
Order Backlog	-	-	-	-	-	94.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.